메뉴 건너뛰기




Volumn 180, Issue 3, 2004, Pages 179-180

Is recombinant Human Erythropoietin Therapy Disadvantageous in Head and Neck Cancer Patients under Radiotherapy?;Verschlechtert die Gabe von rekombinantem humanem Erythropoietin die Prognose von Patienten mit Kopf-Hals-Tumoren unter Radiotherapie?

(1)  Jelkmann, Wolfgang a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERROUS GLUCONATE; IRON SACCHARATE; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

EID: 1542319902     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (1)

References (8)
  • 1
    • 0035328802 scopus 로고    scopus 로고
    • Erythropoietin and erythropoietin receptor expression in human cancer
    • Acs G, Acs P, Beckwith SM, et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 2001;61:3561-5.
    • (2001) Cancer Res , vol.61 , pp. 3561-3565
    • Acs, G.1    Acs, P.2    Beckwith, S.M.3
  • 2
    • 0035400246 scopus 로고    scopus 로고
    • Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
    • Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat. Oncol Biol Phys 2001;50:705-15.
    • (2001) Int J Radiat Oncol Biol Phys , vol.50 , pp. 705-715
    • Glaser, C.M.1    Millesi, W.2    Kornek, G.V.3
  • 3
    • 0142186283 scopus 로고    scopus 로고
    • Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial
    • Henke M, Laszing R, Rübe C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-60.
    • (2003) Lancet , vol.362 , pp. 1255-1260
    • Henke, M.1    Laszing, R.2    Rübe, C.3
  • 4
    • 0041976976 scopus 로고    scopus 로고
    • Breast cancer trial with erythropoietin terminated unexpectedly
    • Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003;4:459-60.
    • (2003) Lancet Oncol , vol.4 , pp. 459-460
    • Leyland-Jones, B.1
  • 5
    • 0036786902 scopus 로고    scopus 로고
    • Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
    • Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002;100:2303-20.
    • (2002) Blood , vol.100 , pp. 2303-2320
    • Rizzo, J.D.1    Lichtin, A.E.2    Woolf, S.H.3
  • 7
    • 0037076925 scopus 로고    scopus 로고
    • Eisen, Infektion und Anämie - Eine klassische Triade
    • Weiss G. Eisen, Infektion und Anämie - eine klassische Triade. Wien Klin Wochenschr 2002;114:357-67.
    • (2002) Wien Klin Wochenschr , vol.114 , pp. 357-367
    • Weiss, G.1
  • 8
    • 0037479926 scopus 로고    scopus 로고
    • Erythropoietin regulates tumour growth of human malignancies
    • 20034
    • Yasuda Y, Fujita Y, Matsuo T, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 20034;24:1021-9.
    • Carcinogenesis , vol.24 , pp. 1021-1029
    • Yasuda, Y.1    Fujita, Y.2    Matsuo, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.